prescription drugs

Latest Headlines

Latest Headlines

Let's address the dark side of Medicare Advantage plans

Medicare Advantage plans are frequently lauded for providing high-quality insurance coverage. And they're widely popular among Medicare-eligible consumers. But there's a dark side to these plans as well. In fact, dozens of federal audit reports indicate that Medicare Advantage plans are making the same kind of deficiencies year after year, especially when it comes to inappropriately rejecting claims. The Centers for Medicare & Medicaid Services found that in 61 percent of the audits, insurers turned down claims for prescription drugs when they shouldn't have. This is not something to take lightly. Many seniors take prescription medications, and many of those drugs are vital to their health and medical conditions. To potentially block their access to those drugs could prove extremely detrimental.

How do we control opioid abuse without hurting chronic pain patients?

Efforts to curb growing rates of prescription painkiller abuse--along with healthcare fraud and wasteful spending riding on their coattails--have made it harder for patients with chronic pain to get the medicines they need.

OIG: Drug companies must do more to stop Part D co-pay coupon abuse

Drug companies aren't doing enough to stop customers from using co-payment coupons to pay for Medicare Part D  prescription drugs, according to a report  by the Office of Inspector General. 

Insurers seek to shift more Rx costs to members

Pa yers have faced allegations of discriminating against patients with certain health conditions; a violation under the Affordable Care Act.  But some insurers are finding ways around the provision by shifting more of the cost of prescriptions onto consumers.  

Cut prescription drug prices to achieve Medicare savings

Given the recent surge in pricey prescription drugs, lawmakers are calling for Medicare to offer rebates and negotiate prices to reap significant savings, according to a report released Wednesday by advocacy groups the Medicare Rights Center and Social Security Works.

Admitted and alleged drug scammers nabbed in 5 states

The challenges of controlling prescirption drug-related fraud are clear as these schemes continue to make news.      

How to control prescription drug costs

Choosing costly prescription drugs over cheaper alternatives drains Medicare of $29 billion per decade, a Health Affairs  study found.

OIG eyes drug company 'conduit' charities

The Office of Inspector General issued guidance last week to control fraud and abuse linked with independent charity patient assistance programs (PAP) for federal healthcare program beneficiaries.

Report questions safety, efficacy of pricey hepatitis C drug Sovaldi

Recent studies of the hepatitis C drug Sovaldi are of poor quality and don't answer pertinent questions about the drug's safety, according to a new report from The Center for Evidence-Based Policy at Oregon Health and Science University.

Will insurer cost-sharing limit consumer access to drugs?

The pharmaceutical industry is concerned that cost-sharing within most health insurance exchange plans could limit consumers' access to necessary medications, says a new report from the Breakaway Health prepared for the Pharmaceutical Research and Manufacturers of America.